Financhill
Back

Brookfield Asset Management Vs. Avidity Biosciences Industry Stock Comparison

Buy
69

BAM
Brookfield Asset Management

Last Price:
47.71
Seasonality Move:
5.35%
Sell
33

RNA
Avidity Biosciences

Last Price:
45.67
Seasonality Move:
-1.3%
Buy
69
Brookfield Asset Management (BAM) is a Buy

Is Brookfield Asset Management a Buy, Sell or Hold?

  • The current Brookfield Asset Management [BAM] share price is $47.70. The Score for BAM is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • BAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BAM Stock Price Chart

What is Brookfield Asset Management's stock price today?

  • The Brookfield Asset Management share price today is $47.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $45.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.

BAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.47 Buy
Relative Strength Index (14 RSI): 79.96 Buy
Chaikin Money Flow: 1070708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.14 - 44.4) Buy
Bollinger Bands (100): (38.29 - 42.29) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 62 Buy
Chaikin Money Flow: 402350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.19 - 44.69) Buy
Bollinger Bands (100): (30.3 - 45.36) Buy

BAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.09 Buy
20-day SMA: 42.71 Buy
50-day SMA: 41.67 Buy
200-day SMA: 40.08 Buy
8-day EMA: 45.15 Buy
20-day EMA: 43.38 Buy
50-day EMA: 41.83 Buy
200-day EMA: 39.44 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.33 Buy
20-day SMA: 42.39 Buy
50-day SMA: 43.82 Buy
200-day SMA: 26.96 Buy
8-day EMA: 43.04 Buy
20-day EMA: 42.7 Buy
50-day EMA: 41.84 Buy
200-day EMA: 30.49 Buy

Brookfield Asset Management Earnings Growth & BAM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.07 per share, an increase this year of $0.05 per share, and an increase next year of $0.26 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.

Brookfield Asset Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):